These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 31484323)

  • 61. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice.
    Xia H; Zhu X; Zhang X; Jiang H; Li B; Wang Z; Li D; Jin Y
    Biomed Pharmacother; 2019 Oct; 118():109287. PubMed ID: 31401392
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice.
    Yang F; Huang P; Shi L; Liu F; Tang A; Xu S
    Drug Des Devel Ther; 2020; 14():3865-3874. PubMed ID: 33061293
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice.
    Tao W; Sun W; Liu L; Wang G; Xiao Z; Pei X; Wang M
    Mar Drugs; 2019 Nov; 17(11):. PubMed ID: 31744059
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Aqueous Extract of Pepino (
    Hsu JY; Lin HH; Hsu CC; Chen BC; Chen JH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037014
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ferulic acid ameliorates nonalcoholic fatty liver disease and modulates the gut microbiota composition in high-fat diet fed ApoE
    Ma Y; Chen K; Lv L; Wu S; Guo Z
    Biomed Pharmacother; 2019 May; 113():108753. PubMed ID: 30856537
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
    Veiga FMS; Graus-Nunes F; Rachid TL; Barreto AB; Mandarim-de-Lacerda CA; Souza-Mello V
    Biochimie; 2017 Sep; 140():106-116. PubMed ID: 28711683
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lycium ruthenicum extract alleviates high-fat diet-induced nonalcoholic fatty liver disease via enhancing the AMPK signaling pathway.
    Lin J; Zhang Y; Wang X; Wang W
    Mol Med Rep; 2015 Sep; 12(3):3835-3840. PubMed ID: 26017330
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
    Elshazly SM
    Eur J Pharmacol; 2015 Feb; 748():123-32. PubMed ID: 25542756
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Kukoamine A attenuates insulin resistance and fatty liver through downregulation of Srebp-1c.
    Li G; Zhou F; Chen Y; Zhang W; Wang N
    Biomed Pharmacother; 2017 May; 89():536-543. PubMed ID: 28254666
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway.
    Chen K; Chen X; Xue H; Zhang P; Fang W; Chen X; Ling W
    Food Funct; 2019 Feb; 10(2):814-823. PubMed ID: 30675881
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.
    Kim JK; Lee KS; Lee DK; Lee SY; Chang HY; Choi J; Lee JI
    Exp Mol Med; 2014 Dec; 46(12):e127. PubMed ID: 25523099
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats.
    Wang Y; Li JY; Han M; Wang WL; Li YZ
    Lipids Health Dis; 2015 Aug; 14():85. PubMed ID: 26242978
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ethanol Extract of
    Le TNH; Choi HJ; Jun HS
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684339
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Deletion of circadian gene Per1 alleviates acute ethanol-induced hepatotoxicity in mice.
    Wang T; Yang P; Zhan Y; Xia L; Hua Z; Zhang J
    Toxicology; 2013 Dec; 314(2-3):193-201. PubMed ID: 24144995
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism.
    Karimi-Sales E; Ebrahimi-Kalan A; Alipour MR
    Biomed Pharmacother; 2019 Jan; 109():1306-1312. PubMed ID: 30551380
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis.
    Chiu CC; Ching YH; Li YP; Liu JY; Huang YT; Huang YW; Yang SS; Huang WC; Chuang HL
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29113135
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non‑alcoholic fatty liver disease mouse model.
    Lu Y; Lin Y; Huang X; Wu S; Wei J; Yang C
    Int J Mol Med; 2019 Jun; 43(6):2398-2408. PubMed ID: 30942432
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Amelioration of the Lipogenesis, Oxidative Stress and Apoptosis of Hepatocytes by a Novel Proteoglycan from Ganoderma lucidum.
    Yuan S; Pan Y; Zhang Z; He Y; Teng Y; Liang H; Wu X; Yang H; Zhou P
    Biol Pharm Bull; 2020 Oct; 43(10):1542-1550. PubMed ID: 32759548
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    Ahn H; Go GW
    J Microbiol Biotechnol; 2017 Apr; 27(4):660-667. PubMed ID: 28081360
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid.
    Wang J; Jiang W
    Med Sci Monit; 2020 Feb; 26():e919220. PubMed ID: 32026851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.